BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 8721901)

  • 1. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F; Ertem U; Taçyildiz N; Kirazli S
    J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.
    Logan TF; Gooding W; Kirkwood JM; Shadduck RK
    Exp Hematol; 1996 Jan; 24(1):49-53. PubMed ID: 8536792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
    Brach MA; Gruss HJ; Asano Y; de Vos S; Ludwig WD; Mertelsmann R; Herrmann F
    Cancer Res; 1992 Apr; 52(8):2197-201. PubMed ID: 1373106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N; Asano S; Matsuda S; Watari K; Takaku F; Nagata S
    Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
    Cucuianu A; Petrov L; Ghiurt A; Vasilache A
    Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of acute leukemia in children].
    Rokicka-Milewska R; Pawelec K; Bogusławska-Jaworska J; Chybicka A; Rosińska B; Stańczak E; Matysiak M; Sońta-Jakimczyk D; Bubała H; Kołecki P; Boruczkowski D; Wysocki M; Kurylak A
    Wiad Lek; 1998; 51 Suppl 4():59-64. PubMed ID: 10731945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia.
    Kamińska T; Hus I; Dmoszyńska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S83-7. PubMed ID: 11665752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 alpha and TNF alpha act synergistically to stimulate production of myeloid colony-stimulating factors by cultured human bone marrow stromal cells and cloned stromal cell strains.
    Caldwell J; Emerson SG
    J Cell Physiol; 1994 May; 159(2):221-8. PubMed ID: 7512974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation.
    Roingeard F; Domenech J; Dayan A; Gihana E; Colombat P; Binet C
    Bone Marrow Transplant; 1995 May; 15(5):741-7. PubMed ID: 7545488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
    Haas R; Gericke G; Witt B; Cayeux S; Hunstein W
    Exp Hematol; 1993 Jan; 21(1):109-13. PubMed ID: 7678083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum granulocyte-macrophage colony-stimulating factor and interleukin-1 levels in patients with repeated and non-repeated pulmonary infections.
    Erduran E; Gedik Y; Aslan Y; Değer O; Oren A
    Turk J Pediatr; 1997; 39(2):203-11. PubMed ID: 9223918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.
    Elbaz O; Budel LM; Hoogerbrugge H; Touw IP; Delwel R; Mahmoud LA; Löwenberg B
    J Clin Invest; 1991 Mar; 87(3):838-41. PubMed ID: 1705566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding of human granulocyte colony-stimulating factor to the blast cells of myeloid leukemia.
    Piao YF; Okabe T
    Cancer Res; 1990 Mar; 50(6):1671-4. PubMed ID: 1689609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.